1,568
Views
36
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma

, , , , , , & show all
Pages 192-200 | Received 30 May 2009, Published online: 08 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

I. Koskivuo, J. Kemppainen, S. Giordano, M. Seppänen, E. Veräjänkorva, P. Vihinen & H. Minn. (2016) Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma. Acta Oncologica 55:11, pages 1355-1359.
Read now

Articles from other publishers (35)

Susann-Cathrin Olthof, Daniel Wessling, Moritz T. Winkelmann, Hansjörg Rempp, Konstantin Nikolaou, Rüdiger Hoffmann & Stephan Clasen. (2022) Single-centre survival analysis over 10 years after MR-guided radiofrequency ablation of liver metastases from different tumour entities. Insights into Imaging 13:1.
Crossref
Mbathio Dieng, Robin M. Turner, Sarah J. Lord, Andrew J. Einstein, Alexander M. Menzies, Robyn P. M. Saw, Omgo E. Nieweg, John F. Thompson & Rachael L. Morton. (2022) Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma. International Journal of Environmental Research and Public Health 19:4, pages 2331.
Crossref
Andrew M. Scott, Sze-Ting Lee, Clare Senko, Marika Ciprotti & Damien Kee. 2020. Nuclear Oncology. Nuclear Oncology 1 35 .
Andrew M. Scott, She-Ting Lee, Clare Senko, Marika Ciprotti & Damien Kee. 2022. Nuclear Oncology. Nuclear Oncology 1235 1269 .
Luke Vale, Patience Kunonga, Diarmuid Coughlan, Vasileios Kontogiannis, Margaret Astin, Fiona Beyer, Catherine Richmond, Dor Wilson, Dalvir Bajwa, Mehdi Javanbakht, Andrew Bryant, Wanwuri Akor, Dawn Craig, Penny Lovat, Marie Labus, Batoul Nasr, Timothy Cunliffe, Helena Hinde, Mohamed Shawgi, Daniel Saleh, Pam Royle, Paul Steward, Rachel Lucas & Robert Ellis. (2021) Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model. Health Technology Assessment 25:64, pages 1-178.
Crossref
Christophe Van de Wiele, Gebreurs Juanito, Borght K. Vander, Ismaheel Lawal, Mike Sathekge, Alex Maes & Bart De Spiegeleer. (2021) Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients. Seminars in Nuclear Medicine 51:6, pages 544-553.
Crossref
Mbathio Dieng, Nikita Khanna, Mai Thi Hoang Nguyen, Robin Turner, Sarah J Lord, Alexander M Menzies, Jay Allen, Robyn Saw, Omgo E Nieweg, John Thompson & Rachael L Morton. (2020) Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol. BMJ Open 10:11, pages e037857.
Crossref
C. Bisschop, E.C. de Heer, A.H. Brouwers, G.A.P. Hospers & M. Jalving. (2020) Rational use of 18F-FDG PET/CT in patients with advanced cutaneous melanoma: A systematic review. Critical Reviews in Oncology/Hematology 153, pages 103044.
Crossref
Kemmei Ikuta, Teruya Kawamoto, Hitomi Hara, Naomasa Fukase, Masayuki Morishita, Ryosuke Kuroda & Toshihiro Akisue. (2020) Solitary pancreatic lesion as the initial metastasis from osteosarcoma: Report of a rare case. Journal of Orthopaedic Science 25:4, pages 724-728.
Crossref
Jacqueline Dinnes, Lavinia Ferrante di Ruffano, Yemisi Takwoingi, Seau Tak Cheung, Paul Nathan, Rubeta N Matin, Naomi Chuchu, Sue Ann Chan, Alana Durack, Susan E Bayliss, Abha Gulati, Lopa Patel, Clare Davenport, Kathie Godfrey, Manil Subesinghe, Zoe Traill, Jonathan J Deeks & Hywel C Williams. (2019) Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. Cochrane Database of Systematic Reviews 2019:7.
Crossref
Montserrat Estorch. 2019. Nuclear Medicine Textbook. Nuclear Medicine Textbook 645 653 .
Richard L. Wahl. 2019. Melanoma. Melanoma 557 581 .
Alireza Rezaee, Andreas Buck, Niklaus Schäfer, Werner Langsteger & Mohsen Beheshti. 2018. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging 221 233 .
Richard L. Wahl. 2017. Melanoma. Melanoma 1 25 .
Eric C. Ehman, Geoffrey B. Johnson, Javier E. Villanueva-Meyer, Soonmee Cha, Andrew Palmera Leynes, Peder Eric Zufall Larson & Thomas A. Hope. (2017) PET/MRI: Where might it replace PET/CT?. Journal of Magnetic Resonance Imaging 46:5, pages 1247-1262.
Crossref
Andrew M. Scott, Marika Ciprotti & Sze-Ting Lee. 2017. Nuclear Oncology. Nuclear Oncology 1065 1102 .
Esther Mena, Mehdi Taghipour, Sara Sheikhbahaei, Sahar Mirpour, Jennifer Xiao & Rathan M. Subramaniam. (2016) 18F-FDG PET/CT and Melanoma. Clinical Nuclear Medicine 41:9, pages e403-e409.
Crossref
Andrew M. Scott, Marika Ciprotti & Sze-Ting Lee. 2016. Nuclear Oncology. Nuclear Oncology 1 39 .
Yael Asman, Amy R. Evenson, Einat Even‐Sapir & Oren Shibolet. (2015) [18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco‐ablative therapies for hepatocellular carcinoma. Liver Transplantation 21:5, pages 572-580.
Crossref
Eric M. Rohren. (2015) PET/Computed Tomography and Patient Outcomes in Melanoma. PET Clinics 10:2, pages 243-254.
Crossref
Nicole J. Look Hong, Teresa Petrella & Kelvin Chan. (2015) Cost-effectiveness analysis of staging strategies in patients with regionally metastatic melanoma. Journal of Surgical Oncology 111:4, pages 423-430.
Crossref
C. Pfannenberg & N. Schwenzer. (2015) Ganzkörperdiagnostik beim malignen MelanomWhole-body staging of malignant melanoma. Der Radiologe 55:2, pages 120-126.
Crossref
Oke Gerke, Ronnie Hermansson, Søren Hess, Søren Schifter, Werner Vach & Poul Flemming Høilund-Carlsen. (2015) Cost-effectiveness of PET and PET/Computed Tomography. PET Clinics 10:1, pages 105-124.
Crossref
Salvatore Annunziata. (2014) Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review. World Journal of Radiology 6:3, pages 48.
Crossref
Renaud Guignard, Matthieu J. Ouvrier, Bruno Krug, Andreas Otte, Jacques Darcourt & Rudi A. J. O. Dierckx. 2014. PET and SPECT in Neurology. PET and SPECT in Neurology 31 57 .
Khun Visith Keu & Andrei H. Iagaru. 2014. Molecular Diagnostics for Melanoma. Molecular Diagnostics for Melanoma 553 580 .
Manil Subesinghe, Maria Marples, Andrew F. Scarsbrook & Jonathan T. Smith. (2013) Clinical impact of 18F-FDG PET-CT in recurrent stage III/IV melanoma: a tertiary centre Specialist Skin Cancer Multidisciplinary Team (SSMDT) experience. Insights into Imaging 4:5, pages 701-709.
Crossref
Abdalmajeid M. Alyassin, Hamza A. Maqsoud, Ahmad M. Mashat, Al-Sayed Al-Mohr & Subhan Abdulwajid. (2013) Feasibility study of gamma-ray medical radiography. Applied Radiation and Isotopes 72, pages 16-29.
Crossref
Kim E. M. van Kessel, Sandra M. E. Geurts, André L. M. Verbeek & Ewout W. Steyerberg. 2013. Patient Surveillance After Cancer Treatment. Patient Surveillance After Cancer Treatment 15 29 .
Andrew M. Scott, Marika Ciprotti & Sze-Ting Lee. 2013. Nuclear Oncology. Nuclear Oncology 635 661 .
Thomas Pfluger, Henriette Ingrid Melzer, Vera Schneider, Christian La Fougere, Eva Coppenrath, Carola Berking, Peter Bartenstein & Mayo Weiss. (2011) PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT. European Journal of Nuclear Medicine and Molecular Imaging 38:5, pages 822-831.
Crossref
Astrid Langer. (2010) A systematic review of PET and PET/CT in oncology: A way to personalize cancer treatment in a cost-effective manner?. BMC Health Services Research 10:1.
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:4, pages 293-304.
Crossref
Massimo Salvatori & Marco Oradei. (2010) Economic evaluation of nuclear medicine procedures. European Journal of Nuclear Medicine and Molecular Imaging 37:9, pages 1786-1792.
Crossref
Bruno Krug, Anne-Sophie Pirson, Ralph Crott & Thierry Vander Borght. (2010) The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma. European Journal of Nuclear Medicine and Molecular Imaging 37:7, pages 1434-1435.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.